Self‐Powered Iontophoretic Transdermal Drug Delivery System Driven and Regulated by Biomechanical Motions
Source abstract
Abstract
Abstract Transdermal drug delivery (TDD) systems with feedback control have attracted extensive research and clinical interest owing to their unique advantages of convenience, self‐administration, and safety. Here, a self‐powered wearable iontophoretic TDD system that can be driven and regulated by the energy harvested from biomechanical motions is proposed for closed‐loop motion detection and therapy. A wearable triboelectric nanogenerator (TENG) is used as the motion sensor and energy harvester that can convert biomechanical motions into electricity for iontophoresis without stored‐energy power sources, while a hydrogel‐based soft patch with side‐by‐side electrodes is designed to enable noninvasive iontophoretic TDD. Proof‐of‐concept experiments on pig skin with dyes as model drugs successfully demonstrate the feasibility of the proposed system. This work not only extends the application of TENG in the biomedical field, but may also provide a cost‐effective solution for noninvasive, electrically assisted TDD with closed‐loop sensing and treatment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Sensor and Energy Harvesting Materials · Advancements in Transdermal Drug Delivery · Advanced Materials and Mechanics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Materials Science and Engineering Georgia Institute of Technology Atlanta GA 30332 USA
Wuhan University School of Pharmaceutical Sciences Wuhan 430071 P. R. China
School of Chemical and Biomolecular Engineering Georgia Institute of Technology Atlanta GA 30332 USA
Beijing Institute of Nanoenergy and Nanosystems Chinese Academy of Sciences Beijing 100083 P. R. China
Funding
China Scholarship Council · Wuhan University
References (35)
Show source-provided references
1. 10.1038/nbt.150410.1038/nbt.1504 ↗
2. 10.1002/adma.20160659610.1002/adma.201606596 ↗
3. 10.1002/adma.20170532810.1002/adma.201705328 ↗
4. 10.1002/adma.20170453010.1002/adma.201704530 ↗
5. 10.1038/nnano.2016.3810.1038/nnano.2016.38 ↗
6. 10.1021/acsnano.5b0397510.1021/acsnano.5b03975 ↗
7. 10.1016/j.addr.2003.10.02610.1016/j.addr.2003.10.026 ↗
8. 10.1063/1.491560710.1063/1.4915607 ↗
9. 10.1016/j.ijpharm.2015.11.02310.1016/j.ijpharm.2015.11.023 ↗
10. 10.3109/1061186X.2015.109044210.3109/1061186X.2015.1090442 ↗
11. 10.3390/s1905102810.3390/s19051028 ↗
12. 10.1002/adhm.20140045710.1002/adhm.201400457 ↗
13. 10.1002/aenm.20180290610.1002/aenm.201802906 ↗
14. 10.1016/j.nanoen.2018.01.00410.1016/j.nanoen.2018.01.004 ↗
15. 10.1002/adfm.20160437810.1002/adfm.201604378 ↗
16. 10.1002/adma.20160352710.1002/adma.201603527 ↗
17. 10.1126/sciadv.150147810.1126/sciadv.1501478 ↗
18. 10.1002/adma.20160566810.1002/adma.201605668 ↗
19. 10.1002/adma.20180779510.1002/adma.201807795 ↗
20. 10.1038/s41467-017-00131-410.1038/s41467-017-00131-4 ↗
21. 10.1002/adfm.20170004910.1002/adfm.201700049 ↗
22. 10.1016/j.mattod.2018.01.00610.1016/j.mattod.2018.01.006 ↗
23. 10.1016/j.bcp.2009.04.03410.1016/j.bcp.2009.04.034 ↗
24. 10.1007/s11095-006-9104-410.1007/s11095-006-9104-4 ↗
25. 10.1016/j.heliyon.2017.e0039010.1016/j.heliyon.2017.e00390 ↗
26. 10.1038/srep2411210.1038/srep24112 ↗
27. 10.1038/nenergy.2016.13810.1038/nenergy.2016.138 ↗
28. 10.1002/adma.20150031110.1002/adma.201500311 ↗
29. 10.1002/adma.20150440310.1002/adma.201504403 ↗
30. 10.1038/ncomms1274410.1038/ncomms12744 ↗
31. 10.1038/ncomms997510.1038/ncomms9975 ↗
32. 10.1016/j.nanoen.2013.08.00210.1016/j.nanoen.2013.08.002 ↗
33. 10.1126/sciadv.170001510.1126/sciadv.1700015 ↗
34. 10.1002/adma.20130239710.1002/adma.201302397 ↗
35. 10.1021/nl400105310.1021/nl4001053 ↗